US giant, Eli Lilly launched Mounjaro (tirzepatide) which is a prescription medicine for adults with type 2 diabetes used ...

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around drug resistant ...

Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...

Indian Pharmaceutical Alliance Pushes for Zero Import Duty on US Drugs to Strengthen Local Industry - The Indian Pharmaceutical Alliance (IPA), representing major drug manufacturers like Cipla , Dr.

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have started manufacturing key medicines for such diseases in the country.

The life of Cipla, the Indian pharma giant, can broadly be divided into three parts: the first 8 decades of altruistic fervour; the second phase - a decade of sharper focus and soaring profits and the ...

Corner office conversation: Cipla CEO on innovation, obesity drugs, AI and more Posted: 3 March 2025 | Last updated: 3 March 2025 The life of Cipla, the Indian pharma giant, can broadly be divided ...